Global 0.9% Sodium Chloride Intravenous Infusion Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global 0.9% Sodium Chloride Intravenous Infusion market size was valued at US$ 1358 million in 2024 and is forecast to a readjusted size of USD 1692 million by 2031 with a CAGR of 3.2% during review period.

0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.

The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.

This report is a detailed and comprehensive analysis for global 0.9% Sodium Chloride Intravenous Infusion market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global 0.9% Sodium Chloride Intravenous Infusion market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (US$/Unit), 2020-2031

Global 0.9% Sodium Chloride Intravenous Infusion market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (US$/Unit), 2020-2031

Global 0.9% Sodium Chloride Intravenous Infusion market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (US$/Unit), 2020-2031

Global 0.9% Sodium Chloride Intravenous Infusion market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for 0.9% Sodium Chloride Intravenous Infusion

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global 0.9% Sodium Chloride Intravenous Infusion market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kelun Group, Baxter, Fresenius Kabi, Shijiazhuang No.4 Pharmaceutical, CR Double-Crane, B.Braun, Otsuka, Cisen Pharmaceutical, Hospira (ICU Medical), Huaren Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

0.9% Sodium Chloride Intravenous Infusion market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Flexible Bag
Plastic Bottles
Glass Bottle

Market segment by Application
Hospitals
Clinics
Other

Major players covered
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe 0.9% Sodium Chloride Intravenous Infusion product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of 0.9% Sodium Chloride Intravenous Infusion, with price, sales quantity, revenue, and global market share of 0.9% Sodium Chloride Intravenous Infusion from 2020 to 2025.

Chapter 3, the 0.9% Sodium Chloride Intravenous Infusion competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the 0.9% Sodium Chloride Intravenous Infusion breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and 0.9% Sodium Chloride Intravenous Infusion market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of 0.9% Sodium Chloride Intravenous Infusion.

Chapter 14 and 15, to describe 0.9% Sodium Chloride Intravenous Infusion sales channel, distributors, customers, research findings and conclusion.